Skip to main content

UPSHER-SMITH 25 mg (Topiramate Extended-Release 25 mg)

Pill with imprint UPSHER-SMITH 25 mg is Gray & Pink, Capsule-shape and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Upsher-Smith Laboratories, Inc.

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; seizures; migraine prevention; seizure prevention and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for UPSHER-SMITH 25 mg

Topiramate extended-release 25 mg UPSHER-SMITH 25 mg
Topiramate extended-release 25 mg UPSHER-SMITH 25 mg
Topiramate extended-release 25 mg UPSHER-SMITH 25 mg Front
Topiramate extended-release 25 mg UPSHER-SMITH 25 mg Back

Topiramate Extended-Release

Imprint
UPSHER-SMITH 25 mg
Strength
25 mg
Color
Gray & Pink
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Upsher-Smith Laboratories, Inc.
Inactive Ingredients
microcrystalline cellulose, hypromellose 2910 (6 mPa.s), ethylcellulose (10 mPa.s), diethyl phthalate, titanium dioxide, ferrosoferric oxide, ferric oxide red

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00832-1071 Upsher-Smith Laboratories Inc.
00245-1071 Upsher-Smith Laboratories Inc.

Get help with Imprint Code FAQs.

Related images for "UPSHER-SMITH 25 mg"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.